GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017 What Happens to the FDA if the Government Shuts Down January 17, 2018 Onxeo Plunges After Liver Cancer Drug Fails Late-Stage Study September 11, 2017
Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017
